Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

COVID-19: Answering the Questions, Part 11

In Part 11 of this ongoing COVID-19 series, listen to a brief update on the role of interferons in COVID-19 by Sharon R. Lewin AO, FRACP, PhD, FAHMS.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: October 29, 2020

In Part 11 of this ongoing COVID-19 series, listen to a brief update on the role of interferons in COVID-19 by Sharon R. Lewin AO, FRACP, PhD, FAHMS.

Content based on an online CME program supported by an independent educational grant from Gilead Sciences.

Link to full program: https://www.clinicaloptions.com/infectious-disease/programs/covid19-resources

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Related Content

In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: March 18, 2021

Arthur Kim, MD, provides an update on the latest COVID-19 treatment options and guidelines and answers questions in the CCO Infectious Disease podcast

Arthur Kim, MD Released: March 9, 2021

Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)

Vikramjit Mukherjee, MD Released: February 19, 2021

Sharon R. Lewin, AO, FRACP, PhD, FAHMS, provides an update on COVID-19 emerging variants and answers questions in the CCO Infectious Disease podcast

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: February 12, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue